1. Home
  2. ATRA vs STAI Comparison

ATRA vs STAI Comparison

Compare ATRA & STAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRA
  • STAI
  • Stock Information
  • Founded
  • ATRA 2012
  • STAI 2011
  • Country
  • ATRA United States
  • STAI United States
  • Employees
  • ATRA N/A
  • STAI N/A
  • Industry
  • ATRA Biotechnology: Biological Products (No Diagnostic Substances)
  • STAI
  • Sector
  • ATRA Health Care
  • STAI
  • Exchange
  • ATRA Nasdaq
  • STAI Nasdaq
  • Market Cap
  • ATRA 39.7M
  • STAI 36.3M
  • IPO Year
  • ATRA 2014
  • STAI N/A
  • Fundamental
  • Price
  • ATRA $6.86
  • STAI $1.74
  • Analyst Decision
  • ATRA Buy
  • STAI
  • Analyst Count
  • ATRA 6
  • STAI 0
  • Target Price
  • ATRA $25.70
  • STAI N/A
  • AVG Volume (30 Days)
  • ATRA 71.1K
  • STAI 15.3M
  • Earning Date
  • ATRA 03-07-2025
  • STAI 01-01-0001
  • Dividend Yield
  • ATRA N/A
  • STAI N/A
  • EPS Growth
  • ATRA N/A
  • STAI N/A
  • EPS
  • ATRA N/A
  • STAI N/A
  • Revenue
  • ATRA $128,940,000.00
  • STAI $522,166.00
  • Revenue This Year
  • ATRA N/A
  • STAI N/A
  • Revenue Next Year
  • ATRA N/A
  • STAI N/A
  • P/E Ratio
  • ATRA N/A
  • STAI N/A
  • Revenue Growth
  • ATRA 1404.02
  • STAI N/A
  • 52 Week Low
  • ATRA $5.40
  • STAI $1.23
  • 52 Week High
  • ATRA $20.83
  • STAI $12.19
  • Technical
  • Relative Strength Index (RSI)
  • ATRA 41.62
  • STAI N/A
  • Support Level
  • ATRA $5.94
  • STAI N/A
  • Resistance Level
  • ATRA $7.02
  • STAI N/A
  • Average True Range (ATR)
  • ATRA 0.58
  • STAI 0.00
  • MACD
  • ATRA 0.07
  • STAI 0.00
  • Stochastic Oscillator
  • ATRA 52.36
  • STAI 0.00

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About STAI ScanTech AI Systems Inc. Common stock

ScanTech AI Systems Inc is developing and deploying security screening systems that protect travelers and other public members from criminals, terrorists, and other bad actors. It has developed a proprietary Computed Tomography scanning system that uses fixed-gantry technology to detect explosives, weapons, narcotics, and other contraband.

Share on Social Networks: